Clean Science

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE227W01023
  • NSEID: CLEAN
  • BSEID: 543318
INR
819.15
-3.5 (-0.43%)
BSENSE

Apr 30

BSE+NSE Vol: 4.65 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationUpcoming Result: Clean Science will declare its result soon on 14 May 2026
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.65 lacs (-10.72%) Volume

Shareholding (Mar 2026)

FII

13.39%

Held by 101 FIIs

DII

0.25%

Held by 24 DIIs

Promoter

51.29%

Is Clean Science overvalued or undervalued?

09-Jun-2025

As of September 17, 2021, Clean Science is considered overvalued with a PE ratio of 60.69, significantly higher than its peers, and despite a 12.71% return over the past year, it is trading at a premium compared to its earnings and growth potential.

As of 17 September 2021, the valuation grade for Clean Science has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 60.69, an EV to EBITDA of 40.46, and a PEG ratio of 7.28, all of which suggest that the stock is trading at a premium compared to its earnings and growth potential.<BR><BR>In comparison to its peers, Clean Science's PE ratio is notably higher than Godrej Industries Ltd., which has a PE of 46.63 and is rated as attractive, and Deepak Nitrite Ltd., with a PE of 37.97 and also rated very expensive. This disparity highlights Clean Science's overvaluation relative to its industry peers. Additionally, while Clean Science has shown a 12.71% return over the past year, this is less impressive compared to the Sensex's 7.55% return, reinforcing the notion that the stock may not be justifiably priced at its current levels.

View full answer

When is the next results date for Clean Science?

06-Jun-2025

No Upcoming Board Meetings

Who are the peers of the Clean Science?

03-Jun-2025

Clean Science's peers include Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Fine Organic, Jubilant Ingrev., Anupam Rasayan, and Alkyl Amines. In terms of returns, Jubilant Ingrev. leads with 44.45% over one year, while Clean Science has a return of 14.36%.

Peers: The peers of Clean Science are Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Fine Organic, Jubilant Ingrev., Anupam Rasayan, and Alkyl Amines.<BR><BR>Quality Snapshot: Excellent management risk is observed at Clean Science, Deepak Nitrite, Fine Organic, and Alkyl Amines, while Good management risk is found at Pidilite Inds., SRF, and Jubilant Ingrev. Average management risk is noted at Gujarat Fluoroch, Himadri Special, and Anupam Rasayan. In terms of Growth, Excellent growth is seen at Himadri Special, while Average growth is found at Pidilite Inds., SRF, and Anupam Rasayan. Below Average growth is noted at Clean Science, Deepak Nitrite, Fine Organic, Jubilant Ingrev., Gujarat Fluoroch, and Alkyl Amines. For Capital Structure, Excellent capital structure is observed at Clean Science, Pidilite Inds., SRF, Deepak Nitrite, Fine Organic, and Alkyl Amines, while Good capital structure is found at Himadri Special and Gujarat Fluoroch, and Average capital structure is noted at Anupam Rasayan.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Jubilant Ingrev. at 44.45%, while the lowest is Deepak Nitrite at -9.57%. Clean Science's 1-year return is 14.36%, which is higher than Deepak Nitrite but lower than Jubilant Ingrev. Additionally, the peers with negative six-month returns are Deepak Nitrite, Gujarat Fluoroch, and Aether Industri.

View full answer

Who are in the management team of Clean Science?

16-Jul-2025

As of March 2023, the management team of Clean Science includes Pradeep R Rathi (Chairman), Ashok Ramnarayan Boob (Managing Director), Krishnakumar Ramnarayan Boob (Whole-time Director), and several independent directors, along with a Company Secretary.

As of March 2023, the management team of Clean Science includes the following individuals:<BR><BR>1. Pradeep R Rathi - Chairman & Non Executive Director<BR>2. Ashok Ramnarayan Boob - Managing Director<BR>3. Krishnakumar Ramnarayan Boob - Whole-time Director<BR>4. Sanjay Kothari - Director<BR>5. Ganapati D Yadav - Independent Director<BR>6. Keval Navinchandra Doshi - Independent Director<BR>7. Madhu Dubhashi - Independent Director<BR>8. Mahesh Arvind Kulkarni - Company Secretary & Compliance Officer<BR>9. Siddhartha Ashok Sikchi - Whole-time Director<BR><BR>As of March 2023, the management team of Clean Science comprises a diverse group of leaders with various roles, including executive and independent directors.

View full answer

What does Clean Science do?

17-Jul-2025

Clean Science and Technology Ltd is a mid-cap company in the specialty chemicals industry, reporting net sales of ₹2,637 Cr and a net profit of ₹741 Cr for Q1 2025. Key metrics include a P/E ratio of 59.00 and a market cap of ₹15,326 Cr.

Overview:<BR>Clean Science and Technology Ltd operates in the specialty chemicals industry and is categorized as a mid-cap company.<BR><BR>History:<BR>The company was originally incorporated as 'Sri Distikemi Private Limited' in 2003 and later changed its name to 'Clean Science and Technology Private Limited' in 2006. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 2,637 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 741 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 15,326 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 59.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.14% <BR>Debt-Equity: -0.26 <BR>Return on Equity: 18.67% <BR>Price to Book: 10.78 <BR><BR>Contact Details:<BR>Details: No Company Details Available <BR>Registrar Address: Not available.

View full answer

Who are the top shareholders of the Clean Science?

17-Jul-2025

The top shareholders of Clean Science include promoter Ashok Ramnarayan Boob with 12.8%, 16 mutual fund schemes holding 4.48%, 92 foreign institutional investors with 6.07%, and the highest public shareholder, Anantroop Financial Advisory Services Private Limited, at 3.92%. Individual investors collectively own 7.78% of the shares.

The top shareholders of Clean Science include the promoters, who hold the majority of the shares. The promoter with the highest holding is Ashok Ramnarayan Boob, owning 12.8% of the company. Additionally, there are 16 mutual fund schemes that collectively hold 4.48%, and 92 foreign institutional investors (FIIs) with a combined holding of 6.07%. The highest public shareholder is Anantroop Financial Advisory Services Private Limited, which holds 3.92%. Individual investors also have a notable stake, accounting for 7.78% of the shares.

View full answer

How big is Clean Science?

24-Jul-2025

As of 24th July, Clean Science & Technology Ltd has a market capitalization of 13,995.00 Cr, with recent Net Sales of 985.50 Cr and a Net Profit of 268.54 Cr. Shareholder's Funds are valued at 1,203.16 Cr, and Total Assets amount to 1,396.28 Cr.

As of 24th July, Clean Science & Technology Ltd has a market capitalization of 13,995.00 Cr, categorizing it as a Mid Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 985.50 Cr and a Net Profit of 268.54 Cr.<BR><BR>For the latest annual period ending in March 2024, the Shareholder's Funds were valued at 1,203.16 Cr, while the Total Assets amounted to 1,396.28 Cr.

View full answer

Is Clean Science technically bullish or bearish?

26-Aug-2025

As of August 25, 2025, the technical trend has shifted to a moderately strong bearish stance, indicated by bearish signals from MACD, moving averages, Bollinger Bands, KST, and OBV, along with significant underperformance compared to the Sensex.

As of 25 August 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, a bearish moving average on the daily timeframe, and a bearish reading from Bollinger Bands on the monthly chart. Additionally, the KST and OBV both indicate bearish conditions on the monthly timeframe. The stock has underperformed significantly compared to the Sensex over multiple periods, further supporting the bearish outlook.

View full answer

How has been the historical performance of Clean Science?

06-Nov-2025

Clean Science has shown consistent growth in net sales and profitability, with net sales increasing from 419.30 Cr in March 2020 to 966.64 Cr in March 2025, despite a dip in March 2023. The company also demonstrated strong earnings growth, with profit before tax reaching 356.73 Cr and earnings per share rising to 24.87 in March 2025.

Answer:<BR>The historical performance of Clean Science shows a consistent growth trajectory in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Clean Science has demonstrated significant growth in net sales, increasing from 419.30 Cr in March 2020 to 966.64 Cr in March 2025, with a notable dip in March 2023 at 935.80 Cr. The total operating income followed a similar trend, reaching 966.64 Cr in March 2025. The raw material costs have also risen, from 127.98 Cr in March 2020 to 368.34 Cr in March 2025, while total expenditure (excluding depreciation) increased from 234.02 Cr to 579.02 Cr over the same period. Operating profit (PBDIT) peaked at 512.33 Cr in March 2023 but fell to 426.21 Cr in March 2025. Profit before tax showed a steady increase, reaching 356.73 Cr in March 2025, while profit after tax was 264.41 Cr. The earnings per share (EPS) rose from 13.12 in March 2020 to 24.87 in March 2025, despite a peak of 35.37 in March 2023. The company's total assets grew significantly from 429.88 Cr in March 2020 to 1,599.51 Cr in March 2025, with total liabilities also increasing from 429.88 Cr to 1,599.51 Cr. Cash flow from operating activities improved to 213.00 Cr in March 2025, while the net cash inflow was 9.00 Cr, indicating a positive cash position. Overall, Clean Science has shown robust growth in both revenue and profitability, alongside a solid asset base.

View full answer

Are Clean Science & Technology Ltd latest results good or bad?

31-Jan-2026

Clean Science & Technology Ltd's latest results are concerning, with a 30.10% decline in net profit and an 8.78% drop in revenue year-on-year, marking the lowest quarterly revenue in recent times and indicating operational challenges. The decreased operating margin further raises concerns about the company's future growth prospects.

Clean Science & Technology Ltd's latest results indicate a challenging financial situation. In Q3 FY26, the company reported a net profit of ₹45.88 crore, which represents a significant decline of 30.10% year-on-year. Revenue also fell to ₹219.67 crore, down 8.78% compared to the same quarter last year. This marks the lowest quarterly revenue in recent times.<BR><BR>The operating margin has decreased to 32.86%, reflecting an 810 basis points drop year-on-year, which is the lowest level recorded in the last twelve quarters. The decline in profitability and revenue suggests that the company is facing operational challenges, particularly in managing costs and maintaining pricing power in a competitive market.<BR><BR>Overall, the financial performance points to a negative trend, characterized by deteriorating margins and declining returns, which raises concerns for investors regarding the company's future growth prospects.

View full answer

Has Clean Science & Technology Ltd declared dividend?

01-Feb-2026

Yes, Clean Science & Technology Ltd has declared a dividend of 200%, amounting to ₹4 per share, with an ex-date of February 6, 2026. However, the company's stock has experienced significant negative returns over various periods, indicating challenging performance despite the dividend.

Clean Science & Technology Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 200%<BR>- Amount per share: 4 per share<BR>- Ex-date: 06 Feb 26<BR><BR>Dividend Yield: 0.7%.<BR><BR>Total Returns by Period:<BR>In the 3-month period, the price return was -20.27%, the dividend return was 0.20%, resulting in a total return of -20.07%.<BR><BR>In the 6-month period, the price return was -35.02%, the dividend return was 0.49%, leading to a total return of -34.53%.<BR><BR>For the 1-year period, the price return was -40.82%, the dividend return was 0.55%, culminating in a total return of -40.27%.<BR><BR>Over the 2-year period, the price return was -42.37%, the dividend return was 0.57%, resulting in a total return of -41.8%.<BR><BR>In the 3-year period, the price return was -39.38%, the dividend return was 0.90%, leading to a total return of -38.48%.<BR><BR>For the 4-year period, the price return was -64.48%, the dividend return was 0.98%, culminating in a total return of -63.5%.<BR><BR>In the 5-year period, the price return was 0%, the dividend return was 0%, resulting in a total return of 0.0%.<BR><BR>Overall, while Clean Science & Technology Ltd has declared a substantial dividend, the total returns over various periods indicate significant negative performance, particularly in the longer term. The dividend yield is modest, suggesting that despite the dividend declaration, the company's stock performance has been challenging.

View full answer

Should I buy, sell or hold Clean Science & Technology Ltd?

16-Apr-2026

Why is Clean Science & Technology Ltd falling/rising?

01-May-2026

As of 30-Apr, Clean Science & Technology Ltd's stock price is 819.15, down 0.43%. The stock has shown mixed performance, with a year-to-date decline of 6.66% and a significant drop of 29.99% over the past year, amid poor long-term growth and decreased investor participation.

As of 30-Apr, Clean Science & Technology Ltd's stock price is currently at 819.15, reflecting a decrease of 3.5 points or 0.43%. Despite a recent performance where the stock has gained 3.66% over the last two days, it is underperforming the sector by 0.3% today. <BR><BR>The stock has shown a mixed performance over different time frames. In the past week, it has increased by 2.53%, while in the last month, it has risen significantly by 24.74%. However, year-to-date, the stock is down 6.66%, and it has experienced a substantial decline of 29.99% over the past year. This consistent underperformance against the benchmark, particularly over the last three years, where it has generated negative returns, contributes to the stock's falling price.<BR><BR>Moreover, the company has reported poor long-term growth, with net sales growing at an annual rate of only 12.13% and operating profit at a mere 2.36% over the last five years. Recent financial results have also been disappointing, with a significant drop in profit before tax and profit after tax compared to previous quarters. The return on equity (ROE) has decreased to 17.7, indicating a very expensive valuation with a price-to-book value of 5.8, which is not favorable compared to its peers.<BR><BR>Additionally, there has been a notable decline in investor participation, with delivery volume falling by 45.89% against the five-day average. This decline in trading activity may further pressure the stock price. While the company has high management efficiency and is net-debt free, these positive factors are overshadowed by the negative growth indicators and the stock's overall underperformance in the market.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of 12.13% and Operating profit at 2.36% over the last 5 years

 
2

Negative results in Dec 25

3

With ROE of 17.7, it has a Very Expensive valuation with a 5.8 Price to Book Value

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

INR 8,662 Cr (Small Cap)

stock-summary
P/E

36.00

stock-summary
Industry P/E

42

stock-summary
Dividend Yield

0.73%

stock-summary
Debt Equity

-0.25

stock-summary
Return on Equity

17.68%

stock-summary
Price to Book

5.83

Revenue and Profits:
Net Sales:
220 Cr
(Quarterly Results - Dec 2025)
Net Profit:
46 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.73%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.83%
0.25%
-4.58%
6 Months
-19.33%
0.20%
-19.13%
1 Year
-29.99%
0.51%
-29.48%
2 Years
-37.91%
0.63%
-37.28%
3 Years
-43.3%
0.86%
-42.44%
4 Years
-57.88%
1.07%
-56.81%
5 Years
0%
0%
0.0%

Latest dividend: 2 per share ex-dividend date: Feb-06-2026

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

29-Apr-2026 | Source : BSE

In terms of the referred Regulation 30 read with Schedule III - Part A of SEBI Listing Regulations 2015 we would like to inform you that a conference call for analysts and investors has been scheduled on Thursday 14th May 2026 at 4:00 P.M. (IST) to discuss the audited financial results for the Quarter and Financial year ended 31st March 2026.

Clarification sought from Clean Science and Technology Ltd

24-Apr-2026 | Source : BSE

The Exchange has sought clarification from Clean Science and Technology Ltd on April 24 2026 with reference to Movement in Volume.

The reply is awaited.

Clarification About Significant Increase In Volume Of Security.

24-Apr-2026 | Source : BSE

Enclosed is the clarification about significant increase in volume of security.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

14 May 2026

stock-summary
DIVIDEND

Clean Science & Technology Ltd has declared 200% dividend, ex-date: 06 Feb 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
12.13%
EBIT Growth (5y)
2.36%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.81
Tax Ratio
25.97%
Dividend Payout Ratio
21.77%
Pledged Shares
0.64%
Institutional Holding
30.55%
ROCE (avg)
48.11%
ROE (avg)
22.95%

Valuation key factors

Factor
Value
P/E Ratio
36
Industry P/E
42
Price to Book Value
5.84
EV to EBIT
28.88
EV to EBITDA
22.99
EV to Capital Employed
7.48
EV to Sales
8.62
PEG Ratio
NA
Dividend Yield
0.73%
ROCE (Latest)
28.34%
ROE (Latest)
17.68%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

0.6421

Mutual Funds

Held by 18 Schemes (12.49%)

FIIs

Held by 101 FIIs (13.39%)

Promoter with highest holding

Ashokkumar Ramkishan Sikchi Huf (9.96%)

Highest Public shareholder

Amansa Holdings Private Limited (4.37%)

Individual Investors Holdings

11.24%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -10.25% vs 0.77% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -17.23% vs -20.88% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "219.67",
          "val2": "244.75",
          "chgp": "-10.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "72.19",
          "val2": "87.24",
          "chgp": "-17.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.17",
          "val2": "0.07",
          "chgp": "142.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "45.88",
          "val2": "55.43",
          "chgp": "-17.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.86%",
          "val2": "35.64%",
          "chgp": "-2.78%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 5.48% vs 25.17% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 0.66% vs 12.19% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "487.47",
          "val2": "462.15",
          "chgp": "5.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "186.94",
          "val2": "184.34",
          "chgp": "1.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.14",
          "val2": "0.15",
          "chgp": "-6.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "125.50",
          "val2": "124.68",
          "chgp": "0.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "38.35%",
          "val2": "39.89%",
          "chgp": "-1.54%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 0.59% vs 24.65% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -9.95% vs 9.53% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "707.14",
          "val2": "702.97",
          "chgp": "0.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "259.13",
          "val2": "282.84",
          "chgp": "-8.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.31",
          "val2": "0.28",
          "chgp": "10.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "171.38",
          "val2": "190.32",
          "chgp": "-9.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.64%",
          "val2": "40.24%",
          "chgp": "-3.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 22.13% vs -15.42% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 8.35% vs -35.03% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "966.64",
          "val2": "791.49",
          "chgp": "22.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "387.62",
          "val2": "332.07",
          "chgp": "16.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.42",
          "val2": "0.93",
          "chgp": "-54.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "264.41",
          "val2": "244.03",
          "chgp": "8.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.10%",
          "val2": "41.96%",
          "chgp": "-1.86%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
219.67
244.75
-10.25%
Operating Profit (PBDIT) excl Other Income
72.19
87.24
-17.25%
Interest
0.17
0.07
142.86%
Exceptional Items
0.00
0.00
Consolidate Net Profit
45.88
55.43
-17.23%
Operating Profit Margin (Excl OI)
32.86%
35.64%
-2.78%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -10.25% vs 0.77% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -17.23% vs -20.88% in Sep 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
487.47
462.15
5.48%
Operating Profit (PBDIT) excl Other Income
186.94
184.34
1.41%
Interest
0.14
0.15
-6.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
125.50
124.68
0.66%
Operating Profit Margin (Excl OI)
38.35%
39.89%
-1.54%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 5.48% vs 25.17% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 0.66% vs 12.19% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
707.14
702.97
0.59%
Operating Profit (PBDIT) excl Other Income
259.13
282.84
-8.38%
Interest
0.31
0.28
10.71%
Exceptional Items
0.00
0.00
Consolidate Net Profit
171.38
190.32
-9.95%
Operating Profit Margin (Excl OI)
36.64%
40.24%
-3.60%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 0.59% vs 24.65% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -9.95% vs 9.53% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
966.64
791.49
22.13%
Operating Profit (PBDIT) excl Other Income
387.62
332.07
16.73%
Interest
0.42
0.93
-54.84%
Exceptional Items
0.00
0.00
Consolidate Net Profit
264.41
244.03
8.35%
Operating Profit Margin (Excl OI)
40.10%
41.96%
-1.86%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 22.13% vs -15.42% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 8.35% vs -35.03% in Mar 2024

stock-summaryCompany CV
About Clean Science & Technology Ltd stock-summary
stock-summary
Clean Science & Technology Ltd
Small Cap
Specialty Chemicals
Clean Science and Technology Limited was originally incorporated as 'Sri Distikemi Private Limited' on 07 November 2003 in Pune, Maharashtra as a Private Limited Company. Thereafter, name of the Company changed to `Clean Science and Technology Private Limited' pursuant to a resolution passed by Shareholders in an Extra Ordinary General Meeting held on 31 July, 2006.
Company Coordinates stock-summary
Icon
No Company Details Available